Marrone Bio Innovations Inc (MBII) Return on Investment ROI from the first quarter of 2022 to first quarter of 2021 and for the year 2022, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket
 


Marrone Bio Innovations Inc   (NASDAQ: MBII)


Marrone Bio Innovations Inc's ROI from its first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Marrone Bio Innovations Inc's ROI in the first quarter of 2022?
Marrone Bio Innovations Inc recorded a cumulative net loss of $-21 million during 12 months ending in the first quarter of 2022, resulting in a negative return on investment (ROI) of -46.29%.

Within the Consumer Non Cyclical sector 161 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2021 from 0 to 4800.

Definition and Formula of Return on Investment



Return On Investment (Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
Y / Y Investment Change TTM -15.72 % 0.65 % 19.98 % 14.43 % 25.82 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 32 39 52 56 58
Return On Investment (TTM) -46.29 % -32.2 % -27.09 % -29.91 % -30.64 %
MBII's Overall Ranking # 4800 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -12.23 % -9.85 % 2.94 % 3.48 % 4.82 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -21 -17 -15 -17 -16




Return On Investment MBII's Ranking
Within: No.
Industry # 33
Sector # 162
Overall # 4800

Return On Investment Statistics
High Average Low
-26.72 %
-91.5 %
-539.92 %
(Sep 30 2021)   (Dec 31 2013)







Financial Statements
Marrone Bio Innovations Inc's I. Quarter Investments $ 32 Millions MBII's Balance sheet
Marrone Bio Innovations Inc's I. Quarter Income $ -8 Millions Quarterly MBII's Income Statement
MBII's Income by Division See MBII's Income by Division


MBII Annual Return On Investment (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Investments in Millions 39 54 48 35 15
Y / Y Investment Growth -27.01 % 13.13 % 35.22 % 136.39 % -55.23 %
Net Income in Millions -17 -20 -37 -20 -31
Y / Y Net Income Growth - - - - -
Annual Return On Investment -42.06 % -37.4 % -78 % -57.35 % -207.4 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Agricultural Production Industry Roi Trends and Statistics
Consumer Non Cyclical Sector Return On Investment Statistics
Roi Trends for overall market
MBII's Roi Ratio versus Agricultural Production Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MBII's Competitors
Subscribers only: Roi for Marrone Bio Innovations Inc's Suppliers
Subscribers only: Return On Investment for MBII's Customers

Other Ratios
MBII's Roa MBII's Inventory Turnover Ratio MBII's Growth Rates MBII's Dividend Statistics
MBII's Profitability Ratios MBII's Asset Turnover Ratio MBII's Dividend Growth
MBII's Roe MBII's Valuation Ratios MBII's Financial Strength Ratios MBII's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2022, within Consumer Non Cyclical Sector ROI


Date modified: 2026-09-08T15:10:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.